While proGRP is established as a marker for SCLC even in its early stages, our findings suggest that proGRP may be seen as candidate tool to differentiate pneumonia and COPD from the most common NSCLC types in the early stage (4). The gene discussed is GRP; the disease is non-small cell lung carcinoma.